ArticleDiabetes care2009
Population intermediate outcomes of diabetes under pay-for-performance incentives in England from 2004 to 2008.
Article in Diabetes care, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Design and effects of outcome-based payment models in healthcare: a systematic review.The European journal of health economics : HEPAC : health economics in prevention and care · 2019Pooled it
- The equity dimension in evaluations of the quality and outcomes framework: a systematic review.BMC health services research · 2011Pooled it
- Systematic review: Effects, design choices, and context of pay-for-performance in health care.BMC health services research · 2010Pooled it
- Stepwise self-titration of oral glucose-lowering medication using a mobile telephone-based telehealth platform in type 2 diabetes: a feasibility trial in primary care.Journal of diabetes science and technology · 2013Trial
- Trial
- Does the implementation of an incentive scheme increase adherence to diabetes guidelines? A retrospective cohort study of managed care enrollees.BMC health services research · 2023Article
- An innovative model for management of cardiovascular disease risk factors in the low resource setting of Cambodia.Health policy and planning · 2021Article
- Article
- Cost-Effectiveness of a Diabetes Pay-For-Performance Program in Diabetes Patients with Multiple Chronic Conditions.PloS one · 2015Article
- Is a diabetes pay-for-performance program cost-effective under the National Health Insurance in Taiwan?Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2014Observational
- Provider and patient directed financial incentives to improve care and outcomes for patients with diabetes.Current diabetes reports · 2013Article
- Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain).Diabetes care · 2012Article
- Fifteen years of continuous improvement of quality care of type 2 diabetes mellitus in primary care in Catalonia, Spain.International journal of clinical practice · 2012Article
- Effect of financial incentives on incentivised and non-incentivised clinical activities: longitudinal analysis of data from the UK Quality and Outcomes Framework.BMJ (Clinical research ed.) · 2011Article
- Family practices' achievement of diabetes quality of care targets and risk of screen-detected diabetic retinopathy.PloS one · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate diabetes outcomes under a national "pay-for-performance" program. RESEARCH DESIGN AND
methodsData were analyzed for 98% of all English family practices. For each practice, the proportion of diabetic subjects with A1C <or=7.5%, blood pressure <or=145/85 mmHg, and cholesterol <or=5 mmol/l was determined. Practices achieving less than the 25th centile for the A1C target for 2006-2007 were classified as low performing.
resultsThe proportion achieving the A1C target at the median practice increased from 59.1% (interquartile range [IQR] 51.7-65.9) in 2004-2005 to 66.7% (IQR 60.6-72.7) in 2007-2008, blood pressure from 70.9% in 2004-2005 to 80.2% in 2007-2008, and cholesterol from 72.6% in 2004-2005 to 83.6% in 2007-2008. In 2004-2005, 57% of practices were low performing (range by region 42.4-69.9). In 2007-2008, 26% of practices were low performing (range 11.6-37.5).
conclusionsIntroduction of pay-for-performance may be one factor contributing to increasing achievement of targets and reducing problems of low performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.